Disclosure of Events or Information

Update on solar power purchase agreement and acquisition upto 26 stake in Swarnaakshu Solar Power Private Limited

Entry into Marketing and Distribution Agreement for Biosimilars in EU Territories by CuraTeQ Biologics Pvt.Ltd

Classification of Unit- V of Apitoria Pharma Private Limited as VAI by the US FDA

Classification of Unit-II of Eugia Pharma Specialities Limited as OAI by the US FDA

Intimation of order received from GST authorities

Classification of Unit-IV of APL Healthcare Limited as VAI by the US FDA

Press Release - Eugia Pharma announces launch of Pomalidomide Capsules in the US

Clarification on media report, Aurobindo Pharmas P Sarath Chandra Reddy acquitted in Delhi Liquor Scam case

Completion of US FDA Inspection at Unit I of Eugia Pharma Specialities Ltd.,

Press Release - Eugia Pharma receives USFDA Approval for Everolimus Tablets

Incorporation of Engenra Biologics Private Limited

Intimation of Orders received from CGST, Hyderabad

Clarification on news item appearing in https:www.ndtvprofit.com

Press Release - Acrotech Biopharma Inc., Announces FDA Approval of ADQUEYTM difamilast 1 Ointment

Completion of US FDA Inspection at Unit-VII of Aurobindo Pharma Limited, Jedcherla

Outcome of Board Meeting 09.02.2026

Completion of US FDA Inspection at Unit-III of Eugia Pharma Specialities Limited

Clarification on Significant Volume Movement in Companys Shares

Incorporation of a new wholly owned step-down subsidiary in Philippines

CuraTeQ Biologics receives NOC from Health Canada for its biosimilar Dyrupeg

Acquisition of the branded non-oncology prescription formulations business of Khandelwal Laboratories Pvt.Ltd., by Auro Pharma Limited